(NASDAQ: OGI) Organigram Global's forecast annual revenue growth rate of 7.19% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Organigram Global's revenue in 2025 is $163,372,262.On average, 3 Wall Street analysts forecast OGI's revenue for 2025 to be $23,598,623,165, with the lowest OGI revenue forecast at $21,497,155,587, and the highest OGI revenue forecast at $24,820,905,328. On average, 3 Wall Street analysts forecast OGI's revenue for 2026 to be $27,048,755,810, with the lowest OGI revenue forecast at $23,806,357,524, and the highest OGI revenue forecast at $29,487,557,183.
In 2027, OGI is forecast to generate $31,493,869,023 in revenue, with the lowest revenue forecast at $31,493,869,023 and the highest revenue forecast at $31,493,869,023.